오소바이오로직스 시장 - 예측(2026-2031년)

The orthobiologics market is projected to expand at a 4.5% CAGR, attaining USD 8.877 billion in 2031 from USD 6.816 billion in 2025.

The orthobiologics market is experiencing significant growth, driven by the convergence of clinical demand, demographic trends, and technological innovation. These products, which are derived from biological substances and used to treat musculoskeletal conditions, are becoming integral to the management of acute and chronic bone, joint, and soft tissue disorders. The market's expansion is underpinned by a rising global burden of musculoskeletal disease, an increasing volume of traumatic injuries, and a shift towards advanced, biologically-driven treatment modalities.

A primary market driver is the escalating global prevalence of bone diseases and musculoskeletal defects. Conditions such as osteoarthritis, osteoporosis, and chronic joint pain represent a substantial and growing source of disability worldwide. This high prevalence establishes a large and sustained patient population in need of effective orthopedic interventions, creating a foundational demand for orthobiologic solutions that can enhance healing and alleviate pain.

Concurrently, the rising incidence of sports-related and road traffic injuries is a major contributor to market growth. These traumatic events frequently result in significant damage to bones, joints, and soft tissues, necessitating advanced reparative and regenerative treatments. The high annual global volume of such injuries ensures a consistent and significant demand for orthobiologic products used in surgical and therapeutic applications to restore function and accelerate recovery.

Demographic shifts are also profoundly influencing the market. The global aging population is a key factor, as older adults are disproportionately affected by degenerative joint diseases and osteoporosis. This demographic trend directly correlates with an increased incidence of conditions requiring orthopedic care, thereby expanding the addressable patient base for orthobiologic therapies over the long term. Furthermore, rising disposable incomes and improving living standards, particularly in developing economies, are enabling greater access to advanced medical treatments. As patients seek more effective and comfortable care, the demand for sophisticated orthobiologic solutions is expected to rise correspondingly.

Technological advancement, supported by both corporate R&D and governmental initiatives, is a critical force propelling the market forward. Significant public and private investments are being channeled into research focused on next-generation regenerative technologies, including injectable solutions for bone and cartilage regeneration. This commitment to innovation is continuously expanding the therapeutic capabilities and clinical applications of orthobiologics, fostering a dynamic pipeline of new products and treatment approaches.

Geographically, North America is a dominant market, characterized by a high prevalence of arthritis and other musculoskeletal conditions, a robust regulatory and clinical infrastructure, and the presence of leading medical device companies. The region's strong focus on technological adoption and its mature healthcare ecosystem consolidate its leadership position.

The Asia-Pacific region is emerging as one of the fastest-growing markets. This growth is fueled by a high incidence of road traffic accidents, increasing healthcare expenditure, and ongoing technological advancements supported by government investment. The region's large population and rapidly developing healthcare infrastructure present a substantial opportunity for market expansion.

The competitive landscape includes specialized players such as Alphatec Spine, Arthrex, and Bioventus. These companies maintain their market positions through continuous product innovation, with a focus on developing comprehensive solutions for spine surgery, joint restoration, and pain management. The industry's high rate of new product introductions each year reflects a intensely competitive and innovation-driven environment, aimed at improving surgical outcomes and addressing the complex needs of patients with musculoskeletal disorders.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2021 to 2025 & forecast data from 2026 to 2031
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information), and Key Developments among others.

Orthobiologics Market Segmentation:

• By Product
• Stem Cell Therapy
• PRP
• Viscosupplementation
• Bone Marrow Aspirate Concentrate (BMAC)
• Others
• By Application
• Ligament & Tendon Injury
• Osteoarthritis & Degenerative Arthritis
• Spinal Fusion
• Others
• By End-User
• Hospitals
• Orthopedic Clinics
• Others
• By Geography
• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Spain
• Italy
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL ORTHOBIOLOGICS MARKET BY

• 5.1. Introduction
• 5.2. Stem Cell Therapy
• 5.3. PRP
• 5.4. Viscosupplementation
• 5.5. Bone Marrow Aspirate Concentrate (BMCA)
• 5.6. Others

6. GLOBAL ORTHOBIOLOGICS MARKET BY APPLICATION

• 6.1. Introduction
• 6.2. Ligament & Tendon Injury
• 6.3. Osteoarthritis & Degenrative Arthritis
• 6.4. Spinal Fusion
• 6.5. Others

7. GLOBAL ORTHOBIOLOGICS MARKET BY END-USER

• 7.1. Introduction
• 7.2. Hospitals
• 7.3. Orthopedo Clinics
• 7.4. Others

8. GLOBAL ORTHOBIOLOGICS MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. USA
  • 8.2.2. Canada
  • 8.2.3. Mexico
• 8.3. South America
  • 8.3.1. Brazil
  • 8.3.2. Argentina
  • 8.3.3. Others
• 8.4. Europe
  • 8.4.1. Germany
  • 8.4.2. France
  • 8.4.3. United Kingdom
  • 8.4.4. Spain
  • 8.4.5. Italy
  • 8.4.6. Others
• 8.5. Middle East and Africa
  • 8.5.1. Saudi Arabia
  • 8.5.2. UAE
  • 8.5.3. Israel
  • 8.5.4. Others
• 8.6. Asia Pacific
  • 8.6.1. China
  • 8.6.2. India
  • 8.6.3. Japan
  • 8.6.4. South Korea
  • 8.6.5. Indonesia
  • 8.6.6. Thailand
  • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Competitive Dashboard

10. COMPANY PROFILES

• 10.1. Alphatec Spine, Inc.
• 10.2. Arthrex Inc.
• 10.3. Bioventus LLC
• 10.4. Exactech, Inc.
• 10.5. Integra Lifesciences
• 10.6. Medtronic Plc
• 10.7. MTF Biologics
• 10.8. Zimmer Biomet
• 10.9. Stryker Corporation
• 10.10. Johnson & Johnson
• 10.11. NuVasive

11. APPENDIX

• 11.1. Currency
• 11.2. Assumptions
• 11.3. Base and Forecast Years Timeline
• 11.4. Key Benefits for the Stakeholders
• 11.5. Research Methodology
• 11.6. Abbreviations